Income statement
USD
Annual
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -186K | -4K | -27K | 0 | 0 |
| Operating Income | -4M | -10M | -6M | -462K | -25K |
| EBITDA | -2M | -98K | -10M | -465K | -25K |
| Net Income | -2M | -10M | -16M | -470K | -25K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Speakeasy Cannabis Club Ltd. (SPBBF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +87.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +87.2%, free cash flow +43.1% with operating margin 0.0% and ROIC -28.2%. Stock Foundry combines SPBBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SPBBF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SPBBF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SPBBF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$24.8K
+94.7% YoY
Free Cash Flow
-$22.5K
+95.9% YoY
Revenue Growth
+0.0%
EPS Growth
+87.2%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -186K | -4K | -27K | 0 | 0 |
| Operating Income | -4M | -10M | -6M | -462K | -25K |
| EBITDA | -2M | -98K | -10M | -465K | -25K |
| Net Income | -2M | -10M | -16M | -470K | -25K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Cash & Equivalents | 94 | 3M | 452K | 527 | 412 |
| Total Assets | 18M | 13M | 4M | 167K | 10K |
| Total Liabilities | 5M | 2M | 701K | 145K | 113K |
| Shareholder Equity | 13M | 11M | 4M | 22K | -103K |
| Total Debt | 3M | 100K | 0 | 0 | 0 |
| Net Debt | 2K | -3M | -452K | -527 | -412 |
Cash flow positioning
Latest Full Year
Operating Cash Flow
22K
+95.9% YoY
Capital Expenditures
0
Free Cash Flow
22K
+95.9% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-16.8%
Debt / Equity
0.23x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.